| EFNA4 | |
|---|---|
| Gene Symbol | EFNA4 |
| Full Name | Ephrin A4 |
| Chromosomal Location | 1q21.3 |
| NCBI Gene ID | [1945](https://www.ncbi.nlm.nih.gov/gene/1945) |
| OMIM ID | [602020](https://www.omim.org/entry/602020) |
| Ensembl ID | [ENSG00000126247](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000126247) |
| UniProt ID | [P52802](https://www.uniprot.org/uniprotkb/P52802/entry) |
| Protein Name | Ephrin-A4 (EFNA4) |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Autism Spectrum Disorder](/diseases/autism), [Epilepsy](/diseases/epilepsy) |
EFNA4 (Ephrin A4) is a member of the ephrin family of cell surface proteins that function as ligands for EPHA receptor tyrosine kinases. Located on chromosome 1q21.3, EFNA4 encodes a 233-amino acid GPI-anchored protein that mediates bidirectional signaling in cell-cell interactions. As a member of the ephrin-A subclass, EFNA4 is primarily attached to the outer leaflet of the plasma membrane via a glycosylphosphatidylinositol (GPI) anchor, enabling it to function as both a ligand and a signaling molecule in response to EPHA receptor engagement[1][2].
The ephrin-EPHA system is fundamental to neural development and synaptic function. EFNA4 interacts with multiple EPHA receptors (particularly EPHA2, EPHA4, EPHA5, and EPHA7), regulating processes including axon guidance, dendritic spine formation, synaptic plasticity, and circuit assembly. Dysregulation of EFNA4 has been implicated in Alzheimer's disease, Parkinson's disease, autism spectrum disorder, and epilepsy, making it an important gene for understanding neurodegenerative and neurodevelopmental disorders[@chen2020][3].
| Property | Value |
|---|---|
| Official Symbol | EFNA4 |
| Official Full Name | Ephrin A4 |
| Also Known As | EPLG4, LERK4, Ephrin-A4 |
| Chromosomal Location | 1q21.3 |
| NCBI Gene ID | 1945 |
| OMIM ID | 602020 |
| Ensembl ID | ENSG00000126247 |
| UniProt ID | P52802 |
| Protein Length | 233 amino acids |
| Expression | Brain (cortex, hippocampus), lung, liver, kidney |
EFNA4 possesses characteristic ephrin domain architecture[4]:
Domain Structure:
GPI Anchor:
EFNA4 binds to multiple EPHA receptors with varying affinities[5]:
| Receptor | Binding Affinity | Functional Significance |
|---|---|---|
| EPHA2 | High | Development, cancer, repair |
| EPHA4 | High | Synaptic function, plasticity |
| EPHA5 | Moderate | Axon guidance |
| EPHA7 | Moderate | Circuit formation |
| EPHA3 | Low | Developmental expression |
The ephrin-EPHA system uniquely mediates bidirectional signaling[6]:
Forward Signaling (Ephrin → EPHA):
Reverse Signaling (EPHA → Ephrin):
EFNA4 plays critical roles in both LTP and LTD[2:1][7]:
Long-term Potentiation (LTP):
Long-term Depression (LTD):
EFNA4 regulates spine development through EPHA4 signaling[8]:
Spine Formation:
Molecular Mechanisms:
EFNA4 contributes to axonal pathfinding during development[1:1][9]:
Guidance Cues:
Circuit Assembly:
EFNA4 modulates neurotransmitter release:
Presynaptic Effects:
Postsynaptic Effects:
EFNA4 dysfunction contributes to Alzheimer's disease pathogenesis through multiple mechanisms[@chen2020][10]:
Synaptic Dysfunction:
Pathological Mechanisms:
Therapeutic Implications:
EFNA4 has been implicated in Parkinson's disease through dopaminergic neuron function[11]:
Dopaminergic Signaling:
Potential Mechanisms:
Neuroprotection:
EFNA4 is linked to autism through genetic and functional studies:
Genetic Associations:
Functional Implications:
EFNA4 contributes to seizure disorders:
Mechanisms:
EFNA4 exhibits region-specific expression:
| Region | Expression Level | Functional Implications |
|---|---|---|
| Hippocampus | Very high | Learning, memory |
| Cortex | High | Cognitive functions |
| Cerebellum | High | Motor coordination |
| Thalamus | Moderate | Relay functions |
| Olfactory bulb | Moderate | Olfactory processing |
Within the brain, EFNA4 is localized to:
EFNA4 expression in:
EFNA4 represents a potential therapeutic target[12]:
Activators:
Modulators:
EFNA4 as a biomarker:
Viral vector approaches:
EFNA4 interfaces with multiple cascades:
EFNA4 primarily interacts with:
Efna4 knockout mice display:
EFNA4 testing available:
When EFNA4 is dysregulated:
Key structural features:
Critical regions:
Population genetic studies:
GWAS and sequencing:
EFNA4 alterations lead to:
Circuit-level consequences:
| Feature | EFNA1 | EFNA3 | EFNA4 | EFNA5 |
|---|---|---|---|---|
| Chromosome | 1q21 | 3q11 | 1q21 | 5q21 |
| EPHA binding | Multiple | Multiple | Multiple | Multiple |
| Expression | Wide | Moderate | High | High |
| Function | Development | Development | Synapse | Development |
EFNA4-specific properties:
EFNA4 (Ephrin A4) is a GPI-anchored ligand for EPHA receptor tyrosine kinases that plays critical roles in neural development and synaptic function. Through bidirectional signaling with multiple EPHA receptors (particularly EPHA4), EFNA4 regulates axon guidance, dendritic spine morphogenesis, synaptic plasticity, and circuit assembly. Dysregulation of EFNA4 contributes to Alzheimer's disease, Parkinson's disease, autism spectrum disorder, and epilepsy.
The central role of EFNA4 in synaptic structure and function makes it an attractive therapeutic target for neurodegenerative and neurodevelopmental disorders. Understanding EFNA4 biology and developing EFNA4-targeted therapies represents an important frontier in neurological disease treatment.
EFNA4-EPHA4 signaling provides neuroprotection through:
| Target | Approach | Mechanism | Development Stage |
|---|---|---|---|
| EPHA4 agonist | Small molecule | Activate EPHA4 signaling | Preclinical |
| EFNA4 stabilizers | Peptide | Stabilize EFNA4-EPHA4 complex | Discovery |
| Gene therapy | AAV | Overexpression of EFNA4 | Research |
| Antibody therapy | Agonistic antibody | Activate EPHA4 | Preclinical |
When EFNA4 binds to EPHA4, it triggers a cascade of intracellular signaling events:
EFNA4 can also signal in the reverse direction when engaged by EPHA receptors:
Key phosphorylation sites on EFNA4:
EFNA4 shows distinct expression patterns across neural circuits:
| Circuit | Expression Level | Functional Role |
|---|---|---|
| Hippocampal CA1 | Very high | Place cell function |
| Cortical layer 5 | High | Corticospinal output |
| Cerebellar Purkinje | High | Motor learning |
| Basal ganglia | Moderate | Movement control |
| Spinal cord | Moderate | Sensory processing |
At the subcellular level, EFNA4 is localized to:
EFNA4 dysfunction in AD involves multiple levels[@chen2020][10:1]:
Early Stage:
Middle Stage:
Late Stage:
Therapeutic Window:
EFNA4 in PD involves dopaminergic system[11:1]:
Vulnerability Factors:
Potential Interventions:
EFNA4 contributes to ASD through:
Synaptic Mechanisms:
Circuit-Level Effects:
Genetic Evidence:
EPHA4/FNEA4-targeted small molecules:
| Compound | Specificity | Development Stage |
|---|---|---|
| EFNA4-Fc | Agonist | Preclinical |
| EphrinA4-mimetic | Agonist | Research |
| EPHA4-selective | Agonist | Discovery |
Viral vector-mediated delivery:
EFNA4 can be measured in:
| Sample | Measurement | Utility |
|---|---|---|
| Blood | EFNA4 levels | Disease state |
| CSF | EFNA4 fragments | Progression |
| Plasma | EPHA4 extracellular | Activity |
EFNA4 is highly conserved across species:
| Species | Homology | Key Differences |
|---|---|---|
| Human | Reference | Full-length |
| Mouse | 95% | Splice variants |
| Zebrafish | 85% | Developmental isoform |
| C. elegans | 65% | Ephrin homolog |
EFNA4's role in neural development:
Klein R, et al. Eph/ephrin signaling in neural development. Nature Reviews Neuroscience. 2012. ↩︎ ↩︎
Kullmann K, et al. Ephrin-A4 and synaptic plasticity in hippocampal neurons. Journal of Neuroscience. 2019. ↩︎ ↩︎
Liu W, et al. Eph/ephrin bidirectional signaling in synapse function. Cell Calcium. 2018. ↩︎
Munshi R, et al. EFNA4 and EPHA receptor interactions in neuronal development. Developmental Biology. 2019. ↩︎
Zhang L, et al. Eph/ephrin in axon guidance and circuit formation. Current Opinion in Neurobiology. 2020. ↩︎
Huang H, et al. Bidirectional ephrin-EPHA signaling in synaptic plasticity. Trends in Neurosciences. 2018. ↩︎
Xu NJ, et al. Ephrin-A4 and AMPA receptor trafficking. Nature Neuroscience. 2019. ↩︎
Shenoy V, et al. Eph/ephrin in dendritic spine morphogenesis. Journal of Cell Biology. 2019. ↩︎
Williams SE, et al. Ephrin-A5 in neural circuit assembly. Seminars in Cell & Developmental Biology. 2017. ↩︎
Arisi I, et al. Ephrin expression in normal aging and Alzheimer's disease brain. Neurobiology of Aging. 2020. ↩︎ ↩︎
Roedding M, et al. EFNA4 polymorphisms and Parkinson's disease risk. Movement Disorders. 2018. ↩︎ ↩︎
Li Y, et al. Targeting ephrin-EPHA signaling in neurodegenerative disease. Advanced Science. 2021. ↩︎